Results 241 to 250 of about 1,261,128 (384)

Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD)

British Journal of Pharmacology, EarlyView.
Background and Purpose Adverse immuno‐inflammatory responses possibly influenced by bacterial compounds reaching the liver as a consequence of altered intestinal permeability appear to be crucial in the pathogenesis of drug‐induced liver injury and steatotic liver diseases.
Daniel E. Di Zeo‐Sánchez, Irene Díaz‐Alberola, José María Pinazo‐Bandera, Miren García‐Cortés, Judith Sanabria‐Cabrera, Mercedes Robles‐Díaz, Ismael Álvarez‐Álvarez, M. Isabel Lucena, Raúl J. Andrade, Marina Villanueva‐Paz, Camilla Stephens   +10 more
wiley   +1 more source

Splenic Vein Thrombosis, Non-Cirrhotic Portal Hypertension, and Gastric Varices in a Patient With Ovarian Carcinoma. [PDF]

J Med Cases
Bowler T, Tiegs L, Megna B, Azeem N.
europepmc   +1 more source

Experimental Study of Hyperdynamic vs. Stagnant Mesenteric Blood Flow in Portal Hypertension

, 1974
Charles L. Witte, Marlys H. Witte, GLEN BAIR, WILLIAM P. MOBLEY, Duncan Morton   +4 more
openalex   +2 more sources

Chronic arsenical poisoning and non-cirrhotic portal hypertension--a case for diagnosis. [PDF]

, 1971

openalex   +1 more source

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

Cancer Science, EarlyView.
CITADEL‐213 evaluated the efficacy and safety of parsaclisib (PI3Kδ inhibitor) in Japanese patients with relapsed or refractory follicular lymphoma (R/R FL). The objective response rate was 88.1%, with 23.8% of patients experiencing a complete response and 64.3% experiencing a partial response; treatment‐emergent adverse events led to parsaclisib ...
Noriko Fukuhara, Isao Yoshida, Takuro Ishiguro, Katsuya Fujimoto, Junya Kuroda, Toshiki Uchida, Ryusuke Yamamoto, Yoshiaki Ogawa, Yasushi Hiramatsu, Toshiro Ito, Seiichiro Katagiri, Tomonori Nakazato, Kazumi Suzukawa, Kenzo Kinami, Mi Zhou, Eiju Negoro   +15 more
wiley   +1 more source

Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension. [PDF]

Diagnostics (Basel)
Bruni A, Dell'Anna G, Samanta J, Fanizza J, Mandarino FV, Dhar J, Facciorusso A, Annese V, Massironi S, Malesci A, Marasco G, Dajti E, Eusebi LH, Barbara G, Donatelli G, Danese S, Fuccio L.   +16 more
europepmc   +1 more source

Portal Systemic Shunt for Portal Hypertension

, 1972
Kuang-Yung Hsu
openalex   +2 more sources

Nutritional Deficiencies Following Bariatric Surgery: A Rapid Systematic Review of Case Reports of Vitamin and Micronutrient Deficiencies Presenting More Than Two Years Post‐Surgery

Clinical Obesity, EarlyView.
ABSTRACT Bariatric surgery is the most clinically‐ and cost‐effective intervention for severe obesity. However, without adequate follow‐up, it can lead to nutritional deficiencies. Patients require life‐long nutritional supplements and follow‐up to prevent nutritional deficiencies from developing.
Sophie Haughton, Sarah Gentry, Helen M. Parretti   +2 more
wiley   +1 more source

A Rare Case of Idiopathic Noncirrhotic Portal Hypertension in a Young Patient. [PDF]

Cureus
Aziz AA, Aziz MA, Amir M, Shah R, Ali IA.   +4 more
europepmc   +1 more source

Combined Caval and Portal Hypertension with Cirrhosis of the Liver

, 1973
Richard E. Welling, William V. McDermott
openalex   +2 more sources